T1	Participants 58 119	patients with hepatitis C virus-related chronic liver disease
T2	Participants 285 351	101 patients with hepatitis C virus-related chronic liver disease.
T3	Participants 360 379	Forty-nine patients
T4	Participants 970 1020	patients who fail to respond to interferon therapy
